drugset / Trial / NCT05294965

Beta 2 Adrenergic Stimulation vs Cold Exposure to Activate Human Brown Adipose Tissue

NCT05294965

Phase 0 Completed 12 enrolled University Hospital, Basel, Switzerland
Non-randomizedCrossoverOpen-labelBasic science

Summary

The purpose of the study is to asses brown adipose tissue activity in humans after intravenous administration of the selective beta-2-adrenergic agonist fenoterol as compared to the natural activator of brown adipose tissue, a mild cold stimulus.

Timeline

Start
2022-04-27
Primary completion
2023-03-06
Completion
2023-03-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenoterol Unknown 1 ug Intravenous

Indications

No indication recorded.